Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Selling, General & Administrative
Aslan Pharmaceuticals Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Selling, General & Administrative
-$5.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Selling, General & Administrative?
Selling, General & Administrative
-5.9m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Selling, General & Administrative amounts to -5.9m USD.
What is Aslan Pharmaceuticals Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
1%
Over the last year, the Selling, General & Administrative growth was 53%. The average annual Selling, General & Administrative growth rates for Aslan Pharmaceuticals Ltd have been 6% over the past three years , 1% over the past five years .